Restoring Inflammatory Mediator Balance after Sofosbuvir-Induced Viral Clearance in Patients with Chronic Hepatitis C

Saraiva, Geórgia Nascimento; Rosário, Natalia Fonseca do; Medeiros, Thalia; Leite, Paulo Emílio Côrrea; Lacerda, Gilmar de Souza; Andrade, Thaís Guaraná de; Azeredo, Elzinandes Leal de; Ancuta, Petronela; Almeida, Jorge Reis; Xavier, Analúcia Rampazzo; Silva, Andrea Alice.
Artículo en Inglés | ARCA | ID: arc-31346

Documentos relacionados

  1. Sofosbuvir-Induced Erythrodermic Pityriasis Rubra Pilaris-Like Drug Eruption.
  2. Anti-Nuclear Cytoplasmic Antibody-Associated Vasculitis: A Probable Adverse Effect of Sofosbuvir Treatment in Chronic Hepatitis C Patients.
  3. Executive summary. Consensus document of GESIDA and SPNS (Spanish Secretariat for the National Plan on AIDS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)
  4. Potential nephrotoxicity of sofosbuvir-based treatment in patients infected with hepatitis C virus: a review on incidence, type and risk factors.
  5. Contrasting Role of Dose Increase in Modulating Sofosbuvir-Induced Hepatocyte Toxicity.